Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

Qualys Conference: ETM and Patch Management Drive Growth Ambitions ↗

Today 13:01 EDT

Via MarketBeat

The Metals Company’s Big Bet Now Comes Down to a License ↗

Today 12:35 EDT

Via MarketBeat

Palvella Therapeutics Eyes 2027 QTORIN Approval as Rare-Disease Pipeline Expands ↗

Today 12:01 EDT

Via MarketBeat

OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings ↗

Today 11:15 EDT

Via MarketBeat

PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal ↗

Today 11:01 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	262.65	-2.48 (-0.94%)
AAPL	305.93	+0.67 (0.22%)
AMD	514.39	+31.38 (6.50%)
BAC	64.49	+0.40 (0.62%)
GOOG	343.54	-0.40 (-0.12%)
META	589.85	-5.12 (-0.86%)
MSFT	495.40	-1.48 (-0.30%)
NVDA	225.16	-0.14 (-0.06%)
ORCL	150.52	-5.70 (-3.65%)
TSLA	342.27	+2.31 (0.68%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.